黄连温胆汤加减联合六君子汤治疗慢性萎缩性胃炎临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3+2

基金项目:


Clinical Study on Modified Huanglian Wendan Tang Combined with Liujunzi Tang for Chronic Atrophic Gastritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察黄连温胆汤加减联合六君子汤治疗慢性萎缩性胃炎(CAG) 的临床疗效。方法:选取121例CAG患者,按随机数字表法分为对照组60例及治疗组61例,2组均使用奥美拉唑肠溶胶囊治疗,对照组在此基础上加用六君子汤,治疗组在对照组基础上加用黄连温胆汤加减治疗。2组均连续治疗4周。观察2组临床疗效,比较2组治疗前后中医证候评分、胃肠激素[胃泌素-17(G17)水平、胃蛋白酶原Ⅰ(PGⅠ)]、炎症因子[白细胞介素17(IL-17) 水平、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)]、免疫功能[CD4+细胞(CD4+)、NK细胞(NK)、CD8+细胞(CD8+)] 水平变化。结果:治疗后,2组食欲不振、贫血、腹痛评分均较治疗前下降,治疗组上述3项中医证候评分均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2组G17、PGⅠ水平均较治疗前上升,治疗组G17、PGⅠ水平均高于对照组,差异均有统计学意义(P<0.05)。治疗后,2组IL-17、TNF-α、CRP水平均较治疗前下降,治疗组上述3项水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2组CD4+、NK水平均较治疗前上升,CD8+水平均较治疗前下降;治疗组CD4+、NK水平均高于对照组,CD8+水平低于对照组,差异均有统计学意义(P<0.05)。治疗组临床疗效总有效率为95.08%,对照组总有效率为81.67%,2 组比较,差异有统计学意义(P<0.05)。结论:黄连温胆汤加减联合六君子汤治疗CAG可缓解其临床症状,有效减轻炎症反应,提高机体免疫力。

    Abstract:

    Abstract:Objective:To observe the clinical effect of modified Huanglian Wendan tang combined with Liujunzi tang for chronic atrophic gastritis(CAG). Methods: A total of 121 cases of CAG patients were selected and divided into the control group and the treatment group according to the random number table method, with 60 and 61 cases in each group respectively. Both groups were treated with omeprazole enteric-coated capsules;the control group was additionally treated with Liujunzi tang, and the treatment group was additionally treated with modified Huanglian Wendan tang based on the treatment of the control group. Both groups were treated for four weeks. The clinical effects in the two groups were observed. Before and after treatment,the changes in Chinese medicine syndrome scores and the levels of gastrointestinal hormones including gastrin- 17(G17) and pepsinogen Ⅰ(PG Ⅰ), inflammatory factors including interleukin 17(IL- 17), tumor necrosis factor α(TNF-α) and C-reactive protein(CRP),and immune function including CD4+ cells(CD4+ ),NK cells(NK) and CD8+ cells (CD8+) in the two groups were compared. Results:After treatment,the scores of poor appetite,anemia and abdominal pain in the two groups were decreased when compared with those before treatment,and the scores of the above three Chinese medicine syndromes in the treatment group were lower than those in the control group, differences being significant(P< 0.05). After treatment, the levels of G17 and PGI in the two groups were increased when compared with those before treatment,and the levels of G17 and PGI in the treatment group were higher than those in the control group,differences being significant(P<0.05). After treatment,the levels of IL- 17,TNF- α and CRP in the two groups were decreased when compared with those before treatment, and the above three levels in the treatment group were lower than those in the control group, differences being significant(P<0.05). After treatment, the levels of CD4 + and NK in the two groups were increased when compared with those before treatment,and CD8+ levels were decreased;the levels of CD4+ and NK in the treatment group were higher than those in the control group, and CD8 + level was lower than that in the control group, differences being significant(P<0.05). The total effective rate of clinical effect was 95.08% in the treatment group and 81.67% in the control group,the difference being significant(P<0.05). Conclusion:The therapy of modified Huanglian Wendan tang combined with Liujunzi tang for CAG can relieve the clinical symptoms,effectively reduce the inflammatory responses and improve the body immunity.

    参考文献
    相似文献
    引证文献
引用本文

陈祝,王建业,刘燕,倪晓红.黄连温胆汤加减联合六君子汤治疗慢性萎缩性胃炎临床研究[J].新中医,2022,54(5):53-57

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-10
  • 出版日期: